MOREin Mesothelioma Study
Patient Michael Lakeland Patient Michael Lakeland

MOREin Mesothelioma Study

DaSH Global in collaboration with Mesothelioma UK have undertaken a prospective cross-sectional study in the UK collecting both Clinical and Patient Reported Outcomes data from a total of 503 Mesothelioma patients.

Read More
Has Pharma done enough to maximise real world evidence?
Patient Michael Lakeland Patient Michael Lakeland

Has Pharma done enough to maximise real world evidence?

It has been good to take a look back at an article I contributed to with NICE and IQWIG in 2014: “Is Pharma doing enough to maximise real world evidence?”. It was interesting to compare “where we were then” to “where we are now” – or should we say, “where we want to be now”?

Read More